Subject: Market Alert: BICX Rebounds Big After Small Selloff

SCV Client Spotlight
Market Alert: BICX Rebounds Big After Small Selloff
Hot Stock to WatchHot Stock to Watch

Company: BioCorRx Inc. (OTCQB: BICX)


Price: 0.17

Change (%): + 0.035 (25.93)

Volume: 39,642
BICX Chart

BioCorRx gears up for battle vs. drug addiction epidemic

Windsor Genova - Fourth Estate Cooperative Contributor Santa Ana, CA, United States (4E) - Drug addiction is an epidemic afflicting millions of people across the globe. In the United States, more than 24 million people above 12 years old are suffering from this malaise in 2012, according to the Substance Abuse and Mental Health Services Association (SAMHSA).

The same organization also reported that more than 20,000 individuals die each year as a result of illicit drug use.

The National Institute on Drug Abuse estimated that drug addiction costs more than $600 billion each year in damages, health care, treatment and prevention. Aside from the staggering cost, drug addiction also has emotional cost to the drug dependent, to the family and to the community. Among the problems stemming from drug addiction are violent behavior, loss of trust, stealing and other criminal activities, and accidental injury or even death.

The number of people suffering from the addiction increased by more than 500 percent in the last 20 years, the SAMHSA report said. The growth has resulted to loss of time and decreased productivity in the workplace, which in the long run have a negative impact on the economy. It is so widespread that it has afflicted even politicians, doctors, teachers, lawyers.

Continue Reading

Like Us on FacebookFollow Us on Twitter

SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that the information is accurate. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from You may opt out of our distribution list at any time by clicking on the "unsubscribe" link below. Link to full disclosure about compensation paid to, Inc. by companies featured on our website or in our e-mail communications.

About Penny Stocks